Efficacy of the serogroup B Neisseria meningitidis vaccine (4CMenB) in preventing experimental Neisseria gonorrhoeae urethral infection: a double-blind randomised controlled human challenge study protocol.
Saved in:
| Title: | Efficacy of the serogroup B Neisseria meningitidis vaccine (4CMenB) in preventing experimental Neisseria gonorrhoeae urethral infection: a double-blind randomised controlled human challenge study protocol. |
|---|---|
| Authors: | Waltmann A; Department of Medicine; Division of Infectious Diseases, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA., Kronk C; Department of Medicine; Division of Infectious Diseases, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA., Lapple D; Department of Medicine; Division of Infectious Diseases, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA., Motley MP; Department of Medicine; Division of Infectious Diseases, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA., Lin FC; Department of Biostatistics, Gillings School of Global Public Health, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Seña AC; Department of Medicine; Division of Infectious Diseases, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA., Hobbs MM; Department of Medicine; Division of Infectious Diseases, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.; Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA., Duncan JA; Department of Medicine; Division of Infectious Diseases, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA Joseph_Duncan@med.unc.edu.; Department of Pharmacology, School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. |
| Source: | BMJ open [BMJ Open] 2026 Apr 28; Vol. 16 (4), pp. e115296. Date of Electronic Publication: 2026 Apr 28. |
| Publication Type: | Journal Article; Clinical Trial Protocol |
| Journal Info: | Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
